Login
Popular Antidepressant Recalled in U.S. Over Cancer-Causing Substance Fears: FDA
A popular antidepressant prescribed globally is being recalled across the United States because it may contain a cancer-causing substance, according to the FDA. Breckenridge Pharmaceutical, Inc. is voluntarily recalling over 14,000 bottles of Duloxetine delayed-release capsules, commonly known as Cymbalta, which are used to treat depression, anxiety, and fibromyalgia, according to the Cleveland Clinic.
The pills are being recalled because they may contain more than the recommended limit of N-nitroso-duloxetine, which deviates from Current Good Manufacturing Practice, set by the FDA. N-nitroso-duloxetine belongs to a class of compounds classified as probable carcinogens for humans.
Product Description: Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured by: Towa Pharmaceutical Europe, S.L. Martorelles (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10
Fentanyl Vaccine Enters Human Trials: Scientific Breakthrough or New Public Health Debate?
A novel fentanyl vaccine designed to block the powerful synthetic opioid from reaching the brain has entered human testing, marking a potentially significant development in the fight against America’s overdose crisis.
Researchers affiliated with ARMR Sciences and the University of Houston report that the vaccine generates antibodies that bind fentanyl in the bloodstream, preventing it from crossing the blood-brain barrier and triggering respiratory depression — the primary cause of fatal overdose.
The investigational product combines a synthetic fentanyl fragment with CRM197, a carrier protein used in existing vaccines, and an adjuvant known as dmLT. Early animal studies demonstrated a substantial reduction in fentanyl’s effects, and a combined Phase 1/2 trial is now underway in the Netherlands.
Brazil Suspends New Dengue Vaccine After Two Suspicious Deaths
Brazil said last Monday (June 8, 2026) that it was temporarily suspending use of the world’s first single-dose dengue vaccine following two suspicious deaths. More than half a million people have received doses of the vaccine this year (2026), which was developed publicly in Brazil and approved by health authorities in November (2025).
It is the first single-dose inoculation against the mosquito-borne dengue virus, which can cause high fever, headaches, muscle pain, nausea and rashes, and is fatal in rare cases. Of the 501,044 people vaccinated between January and May, 3,703 (0.7%) showed symptoms similar to dengue. Forty-two people meanwhile had “more severe reactions”, according to Brazil’s health ministry.
Authorities have recorded three severe cases, including two that resulted in the deaths of a 58-year-old man and a 48-year-old woman. A 38-year-old woman entered intensive care, but has since been discharged.
Wisconsin Beagle Farm Closing, Hundreds of Dogs to Be Sent to Florida Rescue Group
A Wisconsin beagle breeding and research facility that’s been the site of recent violent protests is closing, and its remaining dogs are being taken in by a Florida rescue group.
Big Dog Ranch Rescue announced Monday that it has reached an agreement for the permanent closure of Ridglan Farms and the transfer of its 475 remaining beagles starting this week.
“Not one dog will remain,” Lauree Simmons, the group’s founder, said in a news conference at a farm in Wisconsin. “No more breeding, no more testing, no more anything.”
Yearslong opposition to the facility came to head in April when a large group of animal welfare activists stormed the property in an attempt to take away beagles, prompting police to use tear gas and pepper spray as they made dozens of arrests.
Congo Ebola Outbreak May Be Worst Ever, Africa CDC Says
The head of Africa’s Centres for Disease Control and Prevention warned on Tuesday that the Ebola outbreak in Congo could be the worst ever, saying that currently tens of thousands of contacts of those ill with the disease had not been traced.
“If we don’t stop the outbreak very soon it will be worse than what we had in West Africa and eastern DRC,” Africa CDC Director-General Jean Kaseya told a virtual meeting of African heads of state in Burundi.
He was referring to the outbreak that affected Guinea, Liberia and Sierra Leone in 2014-2016 that killed over 11,000 people and a less deadly 2018 outbreak in Congo.
